Technical Analysis for ANVS - Annovis Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 8.24 | -5.56% | -0.49 |
ANVS closed up 4.31 percent on Wednesday, May 15, 2024, on 1.68 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | -5.56% | |
| 50 DMA Resistance | Bearish | -5.56% | |
| Shooting Star Candlestick | Bearish | -5.56% | |
| Lizard Bearish | Bearish Day Trade Setup | -5.56% | |
| Crossed Above 20 DMA | Bullish | -5.56% | |
| MACD Bullish Signal Line Cross | Bullish | -5.56% | |
| Pocket Pivot | Bullish Swing Setup | -5.56% | |
| Multiple of Ten Bearish | Other | -5.56% | |
| Wide Bands | Range Expansion | -5.56% | |
| Up 3 Days in a Row | Strength | -5.56% |
| Alert | Time |
|---|---|
| 2x Volume Pace | 15 minutes ago |
| 1.5x Volume Pace | 15 minutes ago |
| Up 1% | 23 minutes ago |
| Down 5% | 30 minutes ago |
| Down 3% | 30 minutes ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.49 |
| 52 Week Low | 4.79 |
| Average Volume | 604,007 |
| 200-Day Moving Average | 10.23 |
| 50-Day Moving Average | 9.73 |
| 20-Day Moving Average | 8.43 |
| 10-Day Moving Average | 6.21 |
| Average True Range | 1.65 |
| RSI (14) | 51.22 |
| ADX | 18.53 |
| +DI | 37.03 |
| -DI | 21.65 |
| Chandelier Exit (Long, 3 ATRs) | 15.06 |
| Chandelier Exit (Short, 3 ATRs) | 9.73 |
| Upper Bollinger Bands | 15.42 |
| Lower Bollinger Band | 1.45 |
| Percent B (%b) | 0.52 |
| BandWidth | 165.57 |
| MACD Line | -0.98 |
| MACD Signal Line | -1.13 |
| MACD Histogram | 0.1483 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.58 | ||||
| Resistance 3 (R3) | 11.83 | 11.11 | 11.11 | ||
| Resistance 2 (R2) | 11.11 | 10.38 | 10.99 | 10.95 | |
| Resistance 1 (R1) | 9.92 | 9.93 | 10.51 | 9.67 | 10.79 |
| Pivot Point | 9.20 | 9.20 | 9.50 | 9.08 | 9.20 |
| Support 1 (S1) | 8.01 | 8.47 | 8.61 | 7.77 | 6.65 |
| Support 2 (S2) | 7.29 | 8.02 | 7.17 | 6.49 | |
| Support 3 (S3) | 6.10 | 7.29 | 6.33 | ||
| Support 4 (S4) | 5.86 |
